Antoine Sedrak, Peter MacCallum Cancer Centre, Melbourne, Australia, takes us through his group’s study looking at the perspectives of patients with cancer on a community pharmacy diabetes screening service. He highlights the enablers and barriers to at-risk patients accessing this service. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.